Egypt’s Eva Pharma granted licence to manufacture, distribute Gilead’s COVID-19 drug remdesivir in 127 countries

Egyptian drugmaker Eva Pharma said it had reached a “landmark” deal with Gilead Sciences Inc to become a licensed manufacturer of the US company’s antiviral treatment remdesivir for COVID-19 in 127 countries. Remdesivir, originally developed to treat Ebola, appears to shorten the recovery time of COVID-19 patients. The experimental drug

Tackling COVID-19 in Sub-Saharan Africa

The pandemic-induced crisis will have severe impacts on household incomes and industries in the region and requires swift policy actions.  The COVID-19 infection rates in Sub-Saharan Africa (SSA) have remained modest so far.[1] But with notoriously underfunded health systems[2] and the prevalence of other endemic diseases such as HIV and malaria, many analysts

Amidst A Global Crude Price Crash, Nigeria’s State Oil Firm Is Investing In Healthcare

NPC —the oil corporation through which Nigeria’s federal government regulates and participates in the country’s petroleum industry—wants to build hospitals in response to the coronavirus health emergency, which has thoroughly swept across Africa. The Nigerian National Petroleum Corporation has gone through months of financial troubles that are both connected and